PubMed · 2012 · 12 citations · 0 references
MedicineCardiologySurgeryCardiothoracic SurgeryClinical CardiologyInterventional CardiologyAortic StenosisHeart FailureHemodynamic SupportValvular Heart DiseaseValvular Heart Disease CareHigh-risk Percutaneous Coronary InterventionImpella DevicesLeft Ventricular Assist Device TherapyLeft Ventricular Assist DevicesManagement Of High-risk PatientsSymptomatic Severe Aortic StenosisVentricular Assist Device SupportVentricular Ejection Fraction Assessment
The Impella LP 2.5 left ventricular assist device (Abiomed) is safe and effective for assisting high-risk percutaneous interventions. A 77-year-old woman with severe aortic stenosis, severe coronary artery disease, an ejection fraction of 20%, severe peripheral vascular disease, and other comorbidities presented to a private, tertiary referral hospital with shortness of breath that had been worsening over 2 weeks. The patient underwent a successful, Impella-assisted balloon aortic valvuloplasty (BAV) without complications. Impella support may be considered during BAV in high-risk patients with contraindications for a TandemHeart device (CardiacAssist, Inc.).